首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Effects of N-Acetylcysteine in Ozone-Induced Chronic Obstructive Pulmonary Disease Model
Authors:Feng Li  Cornelis Wiegman  Joanna M Seiffert  Jie Zhu  Colin Clarke  Yan Chang  Pank Bhavsar  Ian Adcock  Junfeng Zhang  Xin Zhou  Kian Fan Chung
Institution:1. Experimental Studies Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.; 2. Department of Respiratory Medicine, the Affiliated First People’s Hospital of Shanghai Jiao Tong University, Shanghai, P.R. China.; 3. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America .; University of California San Francisco, United States of America,
Abstract:

Introduction

Chronic exposure to high levels of ozone induces emphysema and chronic inflammation in mice. We determined the recovery from ozone-induced injury and whether an antioxidant, N-acetylcysteine (NAC), could prevent or reverse the lung damage.

Methods

Mice were exposed to ozone (2.5 ppm, 3 hours/12 exposures, over 6 weeks) and studied 24 hours (24h) or 6 weeks (6W) later. Nac (100 mg/kg, intraperitoneally) was administered either before each exposure (preventive) or after completion of exposure (therapeutic) for 6 weeks.

Results

After ozone exposure, there was an increase in functional residual capacity, total lung volume, and lung compliance, and a reduction in the ratio of forced expiratory volume at 25 and 50 milliseconds to forced vital capacity (FEV25/FVC, FEV50/FVC). Mean linear intercept (Lm) and airway hyperresponsiveness (AHR) to acetylcholine increased, and remained unchanged at 6W after cessation of exposure. Preventive NAC reduced the number of BAL macrophages and airway smooth muscle (ASM) mass. Therapeutic NAC reversed AHR, and reduced ASM mass and apoptotic cells.

Conclusion

Emphysema and lung function changes were irreversible up to 6W after cessation of ozone exposure, and were not reversed by NAC. The beneficial effects of therapeutic NAC may be restricted to the ASM.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号